SCHEMBL7560504

SCHEMBL7560504

O=C(NN=Cc1cccnc1)c1[nH]c2ccccc2c1-c1ccncc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.55
LMNA P02545 3/20 0.55
MEN1 O00255 5/20 0.55
KMT2A Q03164 5/20 0.55
RAB9A P51151 3/20 0.53
POLB P06746 3/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
PAX8 Q06710 1/20 0.49
PADI4 Q9UM07 1/20 0.49
TOP2A P11388 1/20 0.49
TUBB4A P04350 1/20 0.48
TUBB P07437 1/20 0.48
TUBA3C P0DPH7 1/20 0.48
TUBA1B P68363 1/20 0.48
TUBA4A P68366 1/20 0.48
TUBB4B P68371 1/20 0.48
TUBB3 Q13509 1/20 0.48
TUBB2A Q13885 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7560498 1.00 MAPT (0.55) MAPTLMNAMEN1KMT2ARAB9A
SCHEMBL7560543 0.95 LMNA (0.61) MAPTLMNAMEN1KMT2ARAB9A
SCHEMBL7560540 0.95 LMNA (0.61) MAPTLMNAMEN1KMT2ARAB9A
SCHEMBL7559066 0.90 MEN1 (0.51) MAPTLMNAMEN1KMT2ARAB9A
SCHEMBL7559063 0.90 MEN1 (0.51) MAPTLMNAMEN1KMT2ARAB9A
SCHEMBL7560031 0.87 MAPT (0.65) MAPTLMNAMEN1KMT2ARAB9A
SCHEMBL7560034 0.87 MAPT (0.65) MAPTLMNAMEN1KMT2ARAB9A
SCHEMBL7559100 0.86 KMT2A (0.53) MAPTLMNAMEN1KMT2ARAB9A
SCHEMBL7559093 0.86 KMT2A (0.53) MAPTLMNAMEN1KMT2ARAB9A
SCHEMBL7563020 0.86 ALDH1A1 (0.59) MAPTLMNAMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US claimed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO claimed
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
WO-2002022576-A2 3-SUBSTITUTED INDOLE CARBOHYDRAZIDES USEFUL AS CELL PROLIFERATION AND ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 MAPT 4828/4885LMNA 4535/4885MEN1 3165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.